VistaPharm Inc

CorMedix Inc. is a biopharmaceutical company based in Berkeley Heights Twp, NJ, dedicated to developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. Their focus lies in reducing and treating infectious and inflammatory diseases, with a particular emphasis on catheter-related bloodstream infections (CRBSIs) in adult hemodialysis patients. With a strong commitment to research and development, CorMedix Inc. has gained FDA approval for their product, DefenCath, which aims to reduce the incidence of CRBSIs in hemodialysis patients. Through their innovative pipeline and early science initiatives, the company strives to provide therapeutic options that address critical medical needs and improve patient outcomes.Generated from the website

Tripoint Therapeutics is a growth-oriented specialty pharmaceutical company based in Westfield, NJ, with a focus on developing and commercializing high-value products in the areas of CNS, pain, and primary care. With a team of executive management boasting over 60 years of combined pharmaceutical experience, Tripoint partners with various pharmaceutical companies worldwide for acquisitions, licensing, and the development of commercial products and late-stage development assets. As a USA-focused company, Tripoint Therapeutics is dedicated to bringing innovative pharmaceutical solutions to the market, particularly in the fields of central nervous system disorders, pain management, and primary care. Through strategic partnerships and a wealth of industry expertise, Tripoint aims to provide effective treatments and improve the quality of life for patients in need.Generated from the website

Aquestive Therapeutics, Inc. is a leading pharmaceutical company based in Warren, NJ, dedicated to advancing medicines and improving patients' lives through innovative science and delivery technologies. With over 18 years of experience and more than 2 billion doses consumed, Aquestive is a trusted provider of high-quality medications. Their pipeline of medicines aims to overcome barriers faced by patients with existing treatment options and provide new paradigms for treating critical and complex conditions. Aquestive is known for its proprietary PharmFilm technology, which allows for the development and delivery of medications via oral film. This versatile and high-performance drug delivery technology can be tailored to achieve desired product profiles with optimized absorption, bioavailability, and onset of action. The company's focus is on developing orally administered products to provide novel alternatives to invasive and inconvenient standard of care therapies, particularly for central nervous system (CNS) conditions and severe allergies, including anaphylaxis.Generated from the website